Results for tag: "Obinutuzumab"

Obinutuzumab is a type of monoclonal antibody used to treat certain types of leukemia. It is used in combination with other drugs to treat chronic lymphocytic leukemia (CLL) and follicular lymphoma (FL). It works by targeting a protein called CD20, which is found on the surface of certain types of cancer cells. This helps to slow down the growth of cancer cells and can help to reduce the size of tumors. Obinutuzumab is also used to treat non-Hodgkin's lymphoma (NHL). Obinutuzumab is a relatively new drug, having been approved by the US Food and Drug Administration (FDA) in 2013. It is currently available in the US, Europe, and other countries. It is typically administered intravenously, and is usually given in combination with other drugs. Obinutuzumab is marketed by several companies, including Genentech, Novartis, and Roche. It is also available in generic form from several generic drug manufacturers. Show Less Read more